ABEO
ABEONA THERAPEUTICS INC.
NASDAQ · Healthcare · Biotechnology · US
$5.57
−0.36%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 14.91x
- P/S forward
- 3.85x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.49x
- Price / sales
- 12.48x
- Price / cash flow
- -4.17x
Enterprise value
- Enterprise value
- $191.6M
- EV / sales
- 7.51x
- EV / EBITDA
- -2.68x
- EV / EBIT
- -2.29x
- Market cap
- $318.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026